+ Bookmark This Page  
Preferences  |  10:40 PM
  1. Home
  2. Latest News
  3. Submit Press Release
  4. Search Jobs
  5. Search Businesses
  1. News Home
  2. News Archive
  3. By Category
  4. By Location
  5. By Date
  6. By Tag
  7. Newsletter
  8. 40,000 RSS Feeds
  9. Submit Free Press Release
 
Filter News
Category

Country

State / Province
Select Country First

City / Town
Select State First

AnaSpec Introduces Thirty-Two New Catalog Peptides

AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-two (32) new peptides for drug discovery research.
 

FOR IMMEDIATE RELEASE

PRLog (Press Release)Sep 14, 2007 – September 13, 2007 – San Jose, CA

Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-two (32) new peptides for drug discovery research.

Beta-Amyloid A4 Protein Precursor (740-770); APP (C31) - Cat# 62073
Amyloid Precursor Protein (APP) (667-676) - Cat# 62065
Amyloid Precursor Protein (APP) (667-676); Dnp-labeled - Cat# 62074
[Ala10]-beta-Amyloid (1-10) - Cat# 62131
[Cys9]-beta-Amyloid (1-9) - Cat# 62132
Beta-Amyloid (16-20) M - Cat# 61344
Beta-Amyloid (14-23) - Cat# 62024
Beta-Amyloid (1-16); Lys16(HiLyte Fluor TM 488) - Cat# 62002-05
Beta-Amyloid (15–36) - Cat# 62023
[Cys58]105Y; Cell Penetrating Peptide; ?1-antitrypsin (358-374) - Cat# 62005
GRP10; Gastrin-releasing Peptide 10 / Neuromedin C; amidated - Cat# 62095
M1128; Viral Matrix Protein (128-135) - Cat# 62031
R18 Peptide - Cat# 62160
RIAD; FAM labeled - Cat# 62018
PKC zeta 410 - Cat# 62025
Heat Shock Protein 65 (458-474); human - Cat# 62035
Obestatin (11-23); human - Cat# 62041
PyCSP (57–70) Plasmodium Yoelii Circumsporozoite Protein (57–70) - Cat# 62130
Cathepsin D substrate; fluorogenic - Cat# 61860-05
EYK(EYA)3EYK - Cat# 62218
PDGF-BB peptide - Cat# 62192
Alpha-Myosin (735-747) - Cat# 62124
Alpha-Myosin (947-960) - Cat# 62125
Alpha-Myosin (614-643) - Cat# 62126
Alpha-Myosin (614-643) Modified - Cat# 62127
Apidaecin IA - Cat# 62045
Andropin - Cat# 62046
Apidaecin IB - Cat# 62044
VEGFR-2/KDR I; murine - Cat# 62090
TP53 Q9NP68; p53 Mutant Form (361-377); Lys371 (Ac) - Cat# 62121
Bid BH3-R9 - Cat# 62057
Bak-BH3 peptide; Mca labeled - Cat# 62029

Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to pharmaceutical, biotech, and academic research institutions throughout the world. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: peptides, detection reagents, and combinatorial chemistry.  Established in 1993, AnaSpec's headquarters and manufacturing facilities are located in San Jose, CA.

For more information visit www.anaspec.com
# # # + Share This Article Click to see PDF Version of this Press Release

Email to a Friend   Email to Author       Previous News   Next News


Issued By:Albert Hong
Website:http://www.anaspec.com
Email:Click to contact author
Phone:1-408-452-5055
Fax:1-408-452-5059
Categories:Biotech

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases.   Report Abuse


Related

Devilous/ Slanggmedia "get It Now Or Lose It Later" Release Party

AnaSpec Introduces Fifty-Five New Catalog Peptides

Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards

EduCorp Launches New Enterprise-Class Technology Solutions Division, ETC Solutions

2008 Toyota Tundra is Available at Toyota Scion of Concord


Most Viewed (Last 7 days)

LifeCaps to Visit Houston After Hurricane Ike to Promote Survival Kits - 1523 views

Homemade Halloween Decorations Create Halloween Fun - 1294 views

New Music Awards, Announcing The Swi Awards - 874 views

About Designeroutletboutique.com & Additional Discount Coupon Codes - 799 views

The Truth About GPS Technology - 762 views



Previous News

Next News

Are you a Journalist?


For Businesses ...


Tutorial on Free Marketing




  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Use
  5. Copyright Notice